Latin America And Central America Isotretinoin Drugs Market Research Report Forecast to 2030

The LATAM and CAM isotretinoin drugs market is growing because of factors such as the rising prevalence of nodulocystic acne and the increasing incidences of chronic diseases among young adults, such as obesity and diabetes. Furthermore, growing awareness associated with the isotretinoin drug and sound knowledge of maintaining nodulocystic acne further create lucrative growth opportunities. However, side effects associated with the isotretinoin drug and an increasing preference for alternatives are impeding the market's growth.

The drug isotretinoin is used to treat severe nodulocystic acne and other acne that does not respond to other treatments. It works by inhibiting the function of the sebaceous gland and keratinization. Isotretinoin drugs are utilized for the treatment of severe inflammatory acne along with other skin disorders.

Market Segmentation

Based on form, the LATAM and CAM isotretinoin drugs market has been segmented into capsule and gel. The capsule segment dominated the market in 2021 and gel is projected to be the fastest-growing during the forecast period, 2022-2030.

Based on end user, the LATAM and CAM isotretinoin drugs market has been segmented into public sector and private sector.

Regional Analysis

The Latin America and Central America region is driven by several factors, including high consumption of ultra-processed food, alcohol, and smoke, which are the main causes of nodulocystic acne. Moreover, increasing incidences of diabetes, obesity, Polycystic Ovary Syndrome, Diabetes (PCOS), and depression diseases resist insulin, which causes nodular and cystic acne, boosting the market growth. The Latin America region dominated the market in 2021, and Central America is projected to be the fastest-growing during the forecast period, 2022-2030.

Major Players

Cipher Pharmaceuticals (US), Journey Medical Corporation (US), by Viatris Inc. (US), Teva Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories (India), Procaps S.A.(Colombia), Advaita Pharmaceuticals (Mexico), EMS (Brazil), Cipher Pharmaceuticals (Canada), Akorn Operating Company LLC (US), and Stiefel Laboratories (US).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET ANALYSIS

4.1 MARKET INSIGHTS AND PRODUCT ANALYSIS
4.2 ANALYSIS OF REGULATORY LANDSCAPE BY REGION/COUNTRY
- 4.2.1 REGISTRATION REQUIREMENTS FOR ISOTRETINOIN DRUGS, BY COUNTRY
  - 4.2.1.1 MEXICO
  - 4.2.1.2 BRAZIL
  - 4.2.1.3 ARGENTINA
  - 4.2.1.4 COLOMBIA
  - 4.2.1.5 CHILE
  - 4.2.1.6 PERU
  - 4.2.1.7 BOLIVIA
  - 4.2.1.8 URUGUAY
  - 4.2.1.9 VENEZUELA
  - 4.2.1.10 ECUADOR
  - 4.2.1.11 JAMAICA
  - 4.2.1.12 SAINT LUCIA
  - 4.2.1.13 COSTA RICA
  - 4.2.1.14 CENTRAL AMERICA

5 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, BY FORM

5.1 OVERVIEW
5.2 CAPSULE
5.3 GEL

6 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, BY END USER

6.1 OVERVIEW
6.2 PUBLIC SECTOR
6.3 PRIVATE SECTOR

7 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, BY REGION

7.1 OVERVIEW
7.2 LATIN AMERICA
- 7.2.1 MEXICO
- 7.2.2 BRAZIL
- 7.2.3 ARGENTINA
- 7.2.4 COLOMBIA
- 7.2.5 CHILE
- 7.2.6 PERU
- 7.2.7 BOLIVIA
- 7.2.8 URUGUAY
- 7.2.9 VENEZUELA
- 7.2.10 ECUADOR
- 7.2.11 JAMAICA
- 7.2.12 SAINT LUCIA
- 7.2.13 COSTA RICA
- 7.2.14 REST OF LATIN AMERICA
7.3 CENTRAL AMERICA
- 7.3.1 DOMINICAN REPUBLIC
- 7.3.2 PANAMA
- 7.3.3 REST OF CENTRAL AMERICA

8 COMPETITIVE LANDSCAPE

8.1 OVERVIEW
8.2 MARKET SHARE ANALYSIS, 2021

9 APPENDIX

9.1 REFERENCES
9.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 12
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 15
TABLE 1 MARKET INSIGHTS: LIST OF PRODUCTS BY ORIGIN AND AVERAGE PRICE 20
TABLE 2 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 28
TABLE 3 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, FOR CAPSULE, BY REGION, 2018-2030 (USD MILLION) 29
TABLE 4 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, FOR GEL, BY REGION, 2018-2030 (USD MILLION) 29
TABLE 5 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 31
TABLE 6 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, FOR PUBLIC SECTOR, BY REGION, 2018-2030 (USD MILLION) 32
TABLE 7 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, FOR PRIVATE SECTOR, BY REGION, 2018-2030 (USD MILLION) 32
TABLE 8 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, BY REGION, 2018-2030 (USD MILLION) 33
TABLE 9 OBESITY PREVALENCE IN LATIN AMERICA, BY COUNTRY, 2023 34
TABLE 10 LATIN AMERICA: ISOTRETINOIN DRUGS MARKET, BY COUNTRY, 2018-2030 (USD MILLION) 36
TABLE 11 LATIN AMERICA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 37
TABLE 12 LATIN AMERICA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 37
TABLE 13 MEXICO: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 38
TABLE 14 MEXICO: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 38
TABLE 15 BRAZIL: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 38
TABLE 16 BRAZIL: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 39
TABLE 17 ARGENTINA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 39
TABLE 18 ARGENTINA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 39
TABLE 19 COLOMBIA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 40
TABLE 20 COLOMBIA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 40
TABLE 21 CHILE: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 40
TABLE 22 CHILE: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 41
TABLE 23 PERU: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 41
TABLE 24 PERU: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 41
TABLE 25 BOLIVIA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 42
TABLE 26 BOLIVIA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 42
TABLE 27 URUGUAY: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 42
TABLE 28 URUGUAY: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 43
TABLE 29 VENEZUELA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 43
TABLE 30 VENEZUELA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 43
TABLE 31 ECUADOR: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 44
TABLE 32 ECUADOR: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 44
TABLE 33 JAMAICA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 44
TABLE 34 JAMAICA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 45
TABLE 35 SAINT LUCIA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 45
TABLE 36 SAINT LUCIA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 45
TABLE 37 COSTA RICA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 46
TABLE 38 COSTA RICA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 46
TABLE 39 REST OF LATIN AMERICA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 46
TABLE 40 REST OF LATIN AMERICA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 47
TABLE 41 CENTRAL AMERICA: ISOTRETINOIN DRUGS MARKET, BY COUNTRY, 2018-2030 (USD MILLION) 49
TABLE 42 CENTRAL AMERICA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 49
TABLE 43 CENTRAL AMERICA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 50
TABLE 44 DOMINICAN REPUBLIC: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 50
TABLE 45 DOMINICAN REPUBLIC: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 50
TABLE 46 PANAMA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 51
TABLE 47 PANAMA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 51
TABLE 48 REST OF CENTRAL AMERICA: ISOTRETINOIN DRUGS MARKET, BY FORM, 2018-2030 (USD MILLION) 52
TABLE 49 REST OF CENTRAL AMERICA: ISOTRETINOIN DRUGS MARKET, BY END USER, 2018-2030 (USD MILLION) 52
TABLE 50 MAJOR MANUFACTURERS IN LATAM AND CAM ISOTRETINOIN DRUGS MARKET 53

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 10
FIGURE 2 LATAM AND CAM ISOTRETINOIN DRUGS MARKET 11
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 17
FIGURE 4 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, FORM SEGMENT ATTRACTIVENESS, (USD MILLION) 27
FIGURE 1 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, BY FORM, 2021 & 2030 (USD MILLION) 28
FIGURE 2 LATAM AND CAM ISOTRETINOIN DRUGS MARKET SHARE (%), BY FORM, 2021 28
FIGURE 3 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, END USER SEGMENT ATTRACTIVENESS, (USD MILLION) 30
FIGURE 4 LATAM AND CAM ISOTRETINOIN DRUG SMARKET, BY END USER, 2021 & 2030 (USD MILLION) 31
FIGURE 5 LATAM AND CAM ISOTRETINOIN DRUGS MARKET SHARE (%), BY END USER, 2021 31
FIGURE 6 LATAM AND CAM ISOTRETINOIN DRUGS MARKET, BY REGION 2021 & 2030 (USD MILLION) 33
FIGURE 7 LATAM AND CAM ISOTRETINOIN DRUGS MARKET SHARE (%), BY REGION, 2021 34
FIGURE 8 LATIN AMERICA MARKET ANALYSIS: ISOTRETINOIN DRUGS MARKET, 2018-2030 (USD MILLION) 35
FIGURE 9 LATIN AMERICA: ISOTRETINOIN DRUGS MARKET, BY COUNTRY 2021 & 2030 (USD MILLION) 36
FIGURE 10 LATIN AMERICA: ISOTRETINOIN DRUGS MARKET SHARE (%), BY COUNTRY 2021 37
FIGURE 11 CENTRAL AMERICA MARKET ANALYSIS: ISOTRETINOIN DRUGS MARKET, 2018-2030 (USD MILLION) 48
FIGURE 12 CENTRAL AMERICA: ISOTRETINOIN DRUGS MARKET, BY COUNTRY 2021 & 2030 (USD MILLION) 48
FIGURE 13 CENTRAL AMERICA: ISOTRETINOIN DRUGS MARKET SHARE (%), BY COUNTRY 2021 49
FIGURE 14 MARKET SHARE (%) ANALYSIS OF MAJOR PLAYERS, 2021 54